6-fluoromevalonolactone has been researched along with mevalonic acid in 9 studies
| Studies (6-fluoromevalonolactone) | Trials (6-fluoromevalonolactone) | Recent Studies (post-2010) (6-fluoromevalonolactone) | Studies (mevalonic acid) | Trials (mevalonic acid) | Recent Studies (post-2010) (mevalonic acid) |
|---|---|---|---|---|---|
| 10 | 0 | 1 | 3,810 | 33 | 922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 6 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuthbert, JA; Lipsky, PE | 3 |
| d'Orchymont, H; Ducep, JB; Jung, MJ; Nave, JF; Piriou, F | 1 |
| Carrel, JE; Doom, JP; McCormick, JP | 1 |
| Ku, EC | 1 |
| Iwama, A; Nara, Y; Sawamura, M; Yamori, Y | 1 |
| Arnaboldi, L; Corsini, A; Ferri, N; Fumagalli, R; Granata, A; Paoletti, R; Quarato, P | 1 |
| Henneman, L; Kulik, W; van Cruchten, AG; Waterham, HR | 1 |
9 other study(ies) available for 6-fluoromevalonolactone and mevalonic acid
| Article | Year |
|---|---|
Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates.
Topics: Cell Division; Cell Line; DNA; Humans; Hydroxymethylglutaryl CoA Reductases; Lipoproteins, LDL; Lovastatin; Lymphocytes; Mevalonic Acid; Sterols | 1991 |
Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
Topics: Humans; In Vitro Techniques; Leukocytes, Mononuclear; Lipid Metabolism; Lipoproteins, LDL; Lovastatin; Lymphocyte Activation; Mevalonic Acid; Proteins; Sterols | 1990 |
Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate.
Topics: Animals; Anticholesteremic Agents; Carboxy-Lyases; Cholesterol; Chromatography, Thin Layer; Hemiterpenes; In Vitro Techniques; Kinetics; Lipids; Liver; Mevalonic Acid; Organophosphorus Compounds; Phosphotransferases; Phosphotransferases (Alcohol Group Acceptor); Phosphotransferases (Phosphate Group Acceptor); Rats; Rats, Inbred Strains | 1985 |
Cantharidin biosynthesis in a blister beetle: inhibition by 6-fluoromevalonate causes chemical disarmament.
Topics: Animals; Cantharidin; Coleoptera; Male; Mevalonic Acid; Reproduction | 1986 |
Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
Topics: Animals; Carboxy-Lyases; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cholesterol; DNA Replication; Genes, ras; Humans; Interleukin-3; Kinetics; Mevalonic Acid; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
Topics: Anticholesteremic Agents; Carboxy-Lyases; Carcinoma, Hepatocellular; Cholesterol; Fatty Acids; Homeostasis; Humans; Kinetics; Liver Neoplasms; Lovastatin; Mevalonic Acid; Structure-Activity Relationship; Tumor Cells, Cultured | 1996 |
Effect of lovastatin and fluoromevalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Carboxy-Lyases; Cell Division; Enzyme Inhibitors; In Vitro Techniques; Lovastatin; Male; Mevalonic Acid; Phosphatidylinositol 3-Kinases; Phosphotransferases (Alcohol Group Acceptor); Platelet-Derived Growth Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Thymidine | 1995 |
[Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
Topics: Animals; Aorta; Benzodiazepines; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Cholesterol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Male; Mevalonic Acid; Muscle, Smooth, Vascular; Oligopeptides; Rats; Rats, Sprague-Dawley; Thiophenes; Tricarboxylic Acids | 1997 |
Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Topics: Alkyl and Aryl Transferases; Bone Density Conservation Agents; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, Liquid; Diphosphonates; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Farnesyltranstransferase; Fibroblasts; Hep G2 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Lymphocytes; Mevalonic Acid; Pamidronate; Prenylation; Signal Transduction; Tandem Mass Spectrometry; Terpenes; Tricarboxylic Acids; Zoledronic Acid | 2011 |